Class information for: |
Basic class information |
| Class id | #P | Avg. number of references |
Database coverage of references |
|---|---|---|---|
| 36100 | 86 | 37.1 | 84% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
| 408 | 3 | CHIM BIOINORGAN//POLO SCI//CARBONIC ANHYDRASE | 29468 |
| 3350 | 2 | VDAC//VOLTAGE DEPENDENT ANION CHANNEL//HEXOKINASE | 1718 |
| 36100 | 1 | SALICYLIDENEAMINO 2 THIOPHENOL//ALPHA AMINOPHENYL CEPHALOPSORINS//APO 27 MONOCLONAL ANTIBODY | 86 |
Terms with highest relevance score |
| rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|---|
| 1 | SALICYLIDENEAMINO 2 THIOPHENOL | authKW | 1136209 | 5% | 80% | 4 |
| 2 | ALPHA AMINOPHENYL CEPHALOPSORINS | authKW | 355066 | 1% | 100% | 1 |
| 3 | APO 27 MONOCLONAL ANTIBODY | authKW | 355066 | 1% | 100% | 1 |
| 4 | BAX BCL XS | authKW | 355066 | 1% | 100% | 1 |
| 5 | BCL1 LEUKEMIA | authKW | 355066 | 1% | 100% | 1 |
| 6 | BENZOTHIADIAZOLE 7 CARBOXYLATES | authKW | 355066 | 1% | 100% | 1 |
| 7 | CEPHALOSPORINS DEGRADATION | authKW | 355066 | 1% | 100% | 1 |
| 8 | COMBINATIONAL DRUG THERAPY | authKW | 355066 | 1% | 100% | 1 |
| 9 | DRUG RESISTANT T VAGINALIS | authKW | 355066 | 1% | 100% | 1 |
| 10 | ENONE FUNCTIONALITY | authKW | 355066 | 1% | 100% | 1 |
Web of Science journal categories |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | Oncology | 375 | 35% | 0% | 30 |
| 2 | Pharmacology & Pharmacy | 146 | 26% | 0% | 22 |
| 3 | Chemistry, Medicinal | 74 | 9% | 0% | 8 |
| 4 | Hematology | 23 | 6% | 0% | 5 |
| 5 | Biochemistry & Molecular Biology | 22 | 17% | 0% | 15 |
| 6 | Cell Biology | 18 | 9% | 0% | 8 |
| 7 | Toxicology | 15 | 5% | 0% | 4 |
| 8 | Parasitiology | 9 | 2% | 0% | 2 |
| 9 | Gerontology | 5 | 1% | 0% | 1 |
| 10 | Biophysics | 4 | 3% | 0% | 3 |
Address terms |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | KHON KEAN HOSP | 355066 | 1% | 100% | 1 |
| 2 | HUMAN MICROBIOL | 337514 | 20% | 6% | 17 |
| 3 | PPG NANOTECNOL FARMACEUT | 177532 | 1% | 50% | 1 |
| 4 | KERTESZETTUDOMANYI KAR | 118354 | 1% | 33% | 1 |
| 5 | HUMAN DIS RELATED GENE GRP | 88765 | 1% | 25% | 1 |
| 6 | SISTEMAS DISPERSOS | 71012 | 1% | 20% | 1 |
| 7 | BIOTECNOL D ALKALAY L | 50722 | 1% | 14% | 1 |
| 8 | SECT INFLAMMATORY BOWEL DIS | 50722 | 1% | 14% | 1 |
| 9 | LONGEV LIFE SCI TECHNOL | 30871 | 2% | 4% | 2 |
| 10 | INTER CORE IL | 27311 | 1% | 8% | 1 |
Journals |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | CANCER LETTERS | 1878 | 9% | 0% | 8 |
| 2 | ANTI-CANCER DRUGS | 1737 | 5% | 0% | 4 |
| 3 | AMERICAN JOURNAL OF CANCER RESEARCH | 449 | 1% | 0% | 1 |
| 4 | LEUKEMIA | 420 | 3% | 0% | 3 |
| 5 | GENETIC ENGINEERING NEWS | 404 | 1% | 0% | 1 |
| 6 | ORVOSI HETILAP | 368 | 1% | 0% | 1 |
| 7 | ARCHIVES OF PHARMACAL RESEARCH | 356 | 2% | 0% | 2 |
| 8 | GERIATRICS & GERONTOLOGY INTERNATIONAL | 347 | 1% | 0% | 1 |
| 9 | JOURNAL OF NATURAL MEDICINES | 345 | 1% | 0% | 1 |
| 10 | BMB REPORTS | 336 | 1% | 0% | 1 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
| Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
|---|---|---|---|---|
| 1 | RAVIV, Z , COHEN, S , REISCHER-PELECH, D , (2013) THE ANTI-CANCER ACTIVITIES OF JASMONATES.CANCER CHEMOTHERAPY AND PHARMACOLOGY. VOL. 71. ISSUE 2. P. 275-285 | 28 | 41% | 17 |
| 2 | PALMIERI, B , IANNITTI, T , CAPONE, S , FLESCHER, E , (2011) A PRELIMINARY STUDY OF THE LOCAL TREATMENT OF PRENEOPLASTIC AND MALIGNANT SKIN LESIONS USING METHYL JASMONATE.EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES. VOL. 15. ISSUE 3. P. 333 -336 | 10 | 77% | 5 |
| 3 | DA SILVA, GBRF , SCARPA, MV , CARLOS, IZ , QUILLES, MB , LIA, RCC , DO EGITO, EST , DE OLIVEIRA, AG , (2015) OIL-IN-WATER BIOCOMPATIBLE MICROEMULSION AS A CARRIER FOR THE ANTITUMOR DRUG COMPOUND METHYL DIHYDROJASMONATE.INTERNATIONAL JOURNAL OF NANOMEDICINE. VOL. 10. ISSUE . P. 585 -594 | 12 | 57% | 1 |
| 4 | ZHENG, LD , LI, D , XIANG, X , TONG, L , QI, M , PU, JR , HUANG, K , TONG, QS , (2013) METHYL JASMONATE ABOLISHES THE MIGRATION, INVASION AND ANGIOGENESIS OF GASTRIC CANCER CELLS THROUGH DOWN-REGULATION OF MATRIX METALLOPROTEINASE 14.BMC CANCER. VOL. 13. ISSUE . P. - | 16 | 37% | 9 |
| 5 | PIRBALOUTI, AG , SAJJADI, SE , PARANG, K , (2014) A REVIEW ( RESEARCH AND PATENTS) ON JASMONIC ACID AND ITS DERIVATIVES.ARCHIV DER PHARMAZIE. VOL. 347. ISSUE 4. P. 229-239 | 21 | 27% | 6 |
| 6 | COHEN, S , FLESCHER, E , (2009) METHYL JASMONATE: A PLANT STRESS HORMONE AS AN ANTI-CANCER DRUG.PHYTOCHEMISTRY. VOL. 70. ISSUE 13-14. P. 1600-1609 | 23 | 25% | 44 |
| 7 | AVILA-ROMAN, J , TALERO, E , DE LOS REYES, C , ZUBIA, E , MOTILVA, V , GARCIA-MAURINO, S , (2016) CYTOTOXIC ACTIVITY OF MICROALGAL-DERIVED OXYLIPINS AGAINST HUMAN CANCER CELL LINES AND THEIR IMPACT ON ATP LEVELS.NATURAL PRODUCT COMMUNICATIONS. VOL. 11. ISSUE 12. P. 1871 -1875 | 11 | 44% | 0 |
| 8 | ELIA, U , FLESCHER, E , (2013) COMBINED CHEMOTHERAPY OR BIOTHERAPY WITH JASMONATES: TARGETING ENERGY METABOLISM FOR CANCER TREATMENT.CURRENT PHARMACEUTICAL BIOTECHNOLOGY. VOL. 14. ISSUE 3. P. 331-341 | 17 | 26% | 3 |
| 9 | JIANG, GS , ZHAO, J , XIAO, XY , TAO, D , GU, CH , TONG, QS , LUO, BF , WANG, LA , ZENG, FQ , (2011) AN N-TERMINAL SMAC PEPTIDE SENSITIZES HUMAN PROSTATE CARCINOMA CELLS TO METHYL JASMONATE-INDUCED APOPTOSIS.CANCER LETTERS. VOL. 302. ISSUE 1. P. 37-46 | 13 | 32% | 7 |
| 10 | BRUCHIM, I , SARFSTEIN, R , REISS, A , FLESCHER, E , WERNER, H , (2014) IGF1R TYROSINE KINASE INHIBITOR ENHANCES THE CYTOTOXIC EFFECT OF METHYL JASMONATE IN ENDOMETRIAL CANCER.CANCER LETTERS. VOL. 352. ISSUE 2. P. 214 -219 | 8 | 38% | 2 |
Classes with closest relation at Level 1 |